Cytopathologist Navigating Familial Thyroid Tumor Syndromes: From Fine-Needle Aspiration to Genetic Referral

Thyroid fine-needle aspiration (FNA) is primarily a lesion-specific diagnostic test; however, when cytomorphologic findings are interpreted alongside clinical and ultrasound features, they may provide important clues to an underlying hereditary thyroid tumor syndrome. Although familial syndromes are rarely diagnosed by cytology alone, cytopathologists play a pivotal role in recognizing patterns that warrant broader evaluation. Suspicion increases when cytologic findings correlate with young patient age, multifocal or multinodular disease, associated syndromic manifestations, or distinctive ultrasound appearances, prompting ancillary studies, targeted reporting, and consideration of genetic counseling or germline testing. Medullary thyroid carcinoma remains the clearest example of this integrated approach. Its characteristic cytomorphology, supported by calcitonin-based ancillary testing, can strongly suggest the diagnosis, whereas germline RET analysis is required to distinguish hereditary from sporadic disease. Cribriform-morular thyroid carcinoma is another important sentinel lesion, as its WNT/β-catenin-driven morphology should raise suspicion for APC-associated familial adenomatous polyposis, despite the recognized occurrence of sporadic APC- or CTNNB1-altered tumors. In contrast, DICER1-associated thyroid disease, PTEN hamartoma tumor syndrome, and nonsyndromic familial nonmedullary thyroid carcinoma lack pathognomonic FNA features. Nevertheless, subtle distinctions may aid recognition. In particular, papillary architectural features occurring with macrofollicular structures may suggest a DICER1-associated lesion. Overall, these observations support a practical framework in which ultrasound findings, cytomorphology, and genetic considerations are interpreted as a unified diagnostic triad. This model clarifies what thyroid cytology can diagnose, what it may reasonably suggest, and what requires further clinical, molecular, and genetic correlation to identify hereditary thyroid neoplasia and optimize patient management and guide appropriate surveillance.